TRPL LLC

Employee Size

2-10

Organization Type

Privately Held

Headquarters

Paramus, NJ

Founded

2013

Built around deep transdermal-drug-delivery expertise, TRPL LLC is a contract research laboratory developing and testing customized drug-delivery systems and products for pharmaceutical, over-the-counter, cosmeceutical, and nutraceutical companies. Its New York and New Jersey laboratories support formulation and product development, with particular strength in in-vitro percutaneous absorption studies and in-vivo models. The scientific team brings more than 75 years of combined experience, including leadership from a former Long Island University pharmaceutical-sciences professor who authored more than 100 research papers.

• CP
  Conrex Pharmaceutical CorporationFounded in 1985 by MIT- and Harvard-trained scientist Dr. Dean Hsieh, Conrex Pharmaceutical develops transdermal drug-delivery technology and therapeutic formulations. The company is best known for Permeation Enhancement Technology™ (PET™), its patented polymer-matrix system for temporarily helping larger active molecules pass through the skin, a platform used in the FDA-approved Testim® testosterone gel and in Conrex’s SESHA Skin Therapy line. After Dr. Hsieh’s death in 1995, his wife and co-founder, Phyllis Hsieh, became president and CEO and guided the company’s expansion into skincare.WEST CHESTER, PA
• Next Step LaboratoriesNext Step Laboratories is a research-driven cosmetic contract manufacturer that develops ingredients and finished formulations for consumer brands. Based in Richmond Hill, the company works closely with chemists and product-development teams, pairing formulation expertise with technologies such as its patent-pending, naturally derived NeXome delivery system. Its development platform includes in vitro and clinical testing, supported by a global network of university and independent researchers.BROOKLYN, NY
• SymbioSymbio is a specialty contract research organization (CRO) running global clinical trials for dermatology, aesthetics, gastroenterology, and inflammatory diseases. With more than 25 years of therapeutic expertise, the company combines a 5,000-plus-site network across 50 countries with stable teams—45% of its staff have worked together for more than 15 years. Through subsidiary Dow Development Laboratories, Symbio also connects clinical research with topical drug formulation and manufacturing in a 23,000-square-foot FDA-registered, cGMP-compliant facility.PORT JEFFERSON, NY
• Velius, LLCVelius, LLC is a research-driven biopharmaceutical company developing prescription and over-the-counter medicines that target or are delivered through the skin. Founded and built by medical professionals, the Great Neck company is led by a surgeon and a pharmacist and has built its portfolio around nanotechnology-enabled film delivery, including products for scar treatment and dermatological conditions. Its intellectual-property portfolio includes patents issued in more than 25 countries and a suite of 19 developed pharmaceuticals.GREAT NECK, NY